Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy

Clinical trial NCT06377072 · COMPLETED

Trial details

NCT number: NCT06377072
Sponsor: Shanghai Hutchison Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cervical Spondylotic Myelopathy

Start date: 2024-05-11
Primary completion: 2026-01-14
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.